No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Moderna stock has fallen over the past four years, but shares got a boost on positive comments about AI. Is MRNA stock a buy ...

Shares of Moderna are trading higher Wednesday after Oracle Chairman Larry Ellison discussed the potential of artificial intelligence (AI) to revolutionize healthcare.

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA approved.

A hearing on RFK Jr.'s appointment as HHS secretary has stalled; physicians protest his appointment and Trump has paused communications.

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

Cryptocurrencies pulled back after President Trump didn't mention crypto in his inauguration address. Shares in MicroStrategy, which also disclosed it had [recently bought another $1.1 billion of bitc ...

Barbara Salami is the VP of Digital for Commercial at Moderna where she is leads digital transformation for Moderna’s new ...

U.S. equities rose at midday on optimism the new tariffs threatened by President Trump won't be as severe as initially believed.

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...